Navidea Biopharmaceuticals, Inc.(NYSE Amex Equities : NAVB)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.10% | 38.41 | 0.9% | $1248.28m | |
| JNJ | Johnson & Johnson | -0.44% | 147.95 | 0.7% | $870.62m | |
| MRK | Merck & Co., Inc. | -0.06% | 80.97 | 0.7% | $637.23m | |
| ABBV | AbbVie, Inc. | -0.57% | 92.39 | 1.9% | $603.09m | |
| BMY | Bristol-Myers Squibb Co. | 1.30% | 61.81 | 1.0% | $599.18m | |
| AZN | AstraZeneca Plc | -0.07% | 55.37 | 1.2% | $573.33m | |
| LLY | Eli Lilly & Co. | 0.07% | 153.03 | 1.1% | $425.60m | |
| NVS | Novartis AG | -0.64% | 82.38 | 0.2% | $142.36m | |
| GSK | GlaxoSmithKline Plc | 0.39% | 40.95 | 0.2% | $136.09m | |
| MIST | Milestone Pharmaceuticals, Inc. | -3.27% | 9.48 | 0.0% | $135.86m | |
| OPK | OPKO Health, Inc. | -3.02% | 5.46 | 11.2% | $129.82m | |
| NVO | Novo Nordisk A/S | -0.02% | 64.63 | 0.1% | $69.68m | |
| RGEN | Repligen Corp. | -3.25% | 147.81 | 7.1% | $68.38m | |
| PRNB | Principia Biopharma, Inc. | -7.86% | 84.67 | 0.0% | $58.39m | |
| SNY | Sanofi | -1.17% | 50.91 | 0.2% | $56.54m |
Company Profile
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.